Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Clinical and Translational Medicine · 2023
DOI: 10.1002/ctm2.1440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Hu Meng und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: COVID-19, Sepsis, Phospholipases A2, Secretory. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NINR NIH HHS, NIAID NIH HHS.
Themen: Sepsis
Abstract (Originalsprache)
Background
Lipids may influence cellular penetrance by viral pathogens and the immune response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 and compared that with infection with other pathogens in patients admitted with acute respiratory distress syndrome to an intensive care unit (ICU).
Methods
Mass spectrometry was used to characterise lipids and relate them to proteins, peripheral cell immunotypes and disease severity.
Results
Circulating phospholipases (sPLA2, cPLA2 (PLA2G4A) and PLA2G2D) were elevated on admission in all ICU groups. Cyclooxygenase, lipoxygenase and epoxygenase products of arachidonic acid (AA) were elevated in all ICU groups compared with controls. sPLA2 predicted severity in COVID‐19 and correlated with TxA2, LTE4 and the isoprostane, iPF2α‐III, while PLA2G2D correlated with LTE4. The elevation in PGD2, like PGI2 and 12‐HETE, exhibited relative specificity for COVID‐19 and correlated with sPLA2 and the interleukin‐13 receptor to drive lymphopenia, a marker of disease severity. Pro‐inflammatory eicosanoids remained correlated with severity in COVID‐19 28 days after admission. Amongst non‐COVID ICU patients, elevations in 5‐ and 15‐HETE and 9‐ and 13‐HODE reflected viral rather than bacterial disease. Linoleic acid (LA) binds directly to SARS‐CoV‐2 and both LA and its di‐HOME products reflected disease severity in COVID‐19. In healthy marines, these lipids rose with seroconversion. Eicosanoids linked variably to the peripheral cellular immune response. PGE2, TxA2 and LTE4 correlated with T cell activation, as did PGD2 with non‐B non‐T cell activation. In COVID‐19, LPS stimulated peripheral blood mononuclear cell PGF2α correlated with memory T cells, dendritic and NK cells while LA and DiHOMEs correlated with exhausted T cells. Three high abundance lipids – ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 – were altered specifically in COVID. LPC‐O‐16:0 was strongly correlated with T helper follicular cell activation and all three negatively correlated with multi‐omic inflammatory pathways and disease severity.
Conclusions
A broad based lipidomic storm is a predictor of poor prognosis in ARDS. Alterations in sPLA2, PGD2 and 12‐HETE and the high abundance lipids, ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 exhibit relative specificity for COVID‐19 amongst such patients and correlate with the inflammatory response to link to disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Hu Meng, Arjun Sengupta, Garret A FitzGerald
Förderung
- NCATS NIH HHS
- NINR NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- Defense Advanced Research Projects Agency
- Defense Health Agency
Zitieren
APA
Meng, H., Sengupta, A., Ricciotti, E., Mrčela, A., Mathew, D., Mazaleuskaya, L. L., Ghosh, S., Brooks, T. G., Turner, A. P., Schanoski, A. S., Lahens, N. F., Tan, A. W., Woolfork, A., Grant, G., Susztak, K., Letizia, A. G., Sealfon, S. C., Wherry, E. J., Laudanski, K., …, & FitzGerald, G. A. (2023). Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1440
Vancouver
Meng H, Sengupta A, Ricciotti E, Mrčela A, Mathew D, Mazaleuskaya LL, et al. Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1440
BibTeX
@article{Meng2023,
author = {Meng, Hu and Sengupta, Arjun and Ricciotti, Emanuela and Mrčela, Antonijo and Mathew, Divij and Mazaleuskaya, Liudmila L and Ghosh, Soumita and Brooks, Thomas G and Turner, Alexandra P and Schanoski, Alessa Soares and Lahens, Nicholas F and Tan, Ai Wen and Woolfork, Ashley and Grant, Greg and Susztak, Katalin and Letizia, Andrew G and Sealfon, Stuart C and Wherry, E John and Laudanski, Krzysztof and Weljie, Aalim M and Meyer, Nuala J and FitzGerald, Garret A},
title = {Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis},
journal = {Clinical and Translational Medicine},
year = {2023},
doi = {10.1002/ctm2.1440}
}
EUVIMED